Abstract
Abstract
Protein kinases become an important source of potential drug targets. Developing new, efficient, and safe small-molecule kinase inhibitors has become an important topic in the field of drug research and development. In contrast with traditional wet experiments which are time-consuming and expensive, machine learning-based approaches for predicting small molecule inhibitors for protein kinases are time-saving and cost-effective that are highly desired for us. However, the issue of sample scarcity (known active and inactive compounds are usually limited for most kinases) poses a challenge for the research and development of machine learning-based kinase inhibitors active prediction methods. To alleviate the data scarcity problem in the prediction of kinase inhibitors, in this study, we present a novel Meta-learning based inductive logistic matrix completion method for the Prediction of Kinase Inhibitors (MetaILMC). MetaILMC adopts a meta-learning framework to learn a well-generalized model from tasks with sufficient samples, which can fast adapt to new tasks with limited samples. As MetaILMC allows the effective transfer of the prior knowledge learned from kinases with sufficient samples to kinases with a small number of samples, the proposed model can produce accurate predictions for kinases with limited data. Experimental results show that MetaILMC has excellent performance for prediction tasks of kinases with few-shot samples and is significantly superior to the state-of-the-art multi-task learning in terms of AUC, AUPR, etc., various performance metrics. Case studies also provided for two drugs to predict Kinase Inhibitory scores, further validating the proposed method's effectiveness and feasibility.
Publisher
Research Square Platform LLC
Reference34 articles.
1. Protein kinase inhibitors: insights into drug design from structure[J];Noble MEM;Science,2004
2. Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update;Roskoski R;Pharmacol Res,2020
3. FDA-approved small-molecule kinase inhibitors[J];Wu P;Trends Pharmacol Sci,2015
4. Kinase-targeted cancer therapies: progress, challenges, and future directions[J];Bhullar KS;Mol Cancer,2018
5. Köstler WJ, Zielinski CC (2015) Targeting Receptor Tyrosine Kinases in Cancer. Receptor Tyrosine Kinases: Structure, Functions, and Role in Human Disease. Spring, New York, pp 225–278